New combo pill targets root cause of stubborn heartburn
NCT ID NCT07174882
Summary
This study is testing if adding a second drug (Rebamipide) to standard acid-reducing medicine works better for people with a common type of acid reflux disease. The goal is to better control symptoms like heartburn and to help strengthen and protect the lining of the esophagus. Researchers will compare the two-drug combination to the standard single drug in 60 patients over four weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-EROSIVE GASTRO-ESOPHAGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
V.Kh.Vasilenko Clinic of Propedeutics of Internal Diseases, Gastroenterology and Hepatology, I.M.Sechenov First Moscow State Medical University (Sechenov University). Gastroenterology department, outpatient clinic.
Moscow, 119991, Russia
Conditions
Explore the condition pages connected to this study.